Eric Claassen

Eric Claassen 0613-41Eric Claassen is 10% academic and 90% entrepreneur. He was also the winner of the Dutch 1 million Euro NGI Valorisation Award for ‘Excellent deal making with Industry”. Furthermore he is active as: President of the Supervisory Board of Viroclinics Biosciences BV and a supervisory board member in:  Bright Move BV (TU Eindhoven) and HOPE BV. He is founder and CEO/Statutory director of ViroNovative BV, Darmgezondheid BV, Medical Delta Multiplier BV and ML Consultancy BV. He is Chairman of the SAB of Pfizer Consumer Health (Probiotics) and Forbion life science venture capital. He was elected chairman (level 1 CTS clearance) of NATO PG32 on Handheld detection of Biological Weapons. Among various memberships of committees he is an elected member of the Netherlands Academy of Technology and Innovation ( and (from 1992-2013) the Dutch Health Council (gezondheidsraad). Eric is a member of the RvT (Board of trustees) of RIA; The City of Rotterdam Investment Agency.

He is appointed as full professor (0 FTE) in “Knowledge Valorisation in the Life Sciences” at Dept. Virology Erasmus MC in Rotterdam where he was professor of Immunology since 1994. In 2005 he was appointed as “Entrepreneur in Residence” at the RSM (Rotterdam School of Management; bedrijfskunde). In 2001 he was appointed as the first Biopartner professor “Entrepreneurship in the Life Sciences” on behalf of the Ministry of Economic Affairs at the Athena Institute, Vrije Universiteit Amsterdam (This chair, which he still holds, was transformed in 2005 to “Business management and Entrepreneurship in Health & Life Sciences Full Professorship 0.1 FTE/4hrs per week). He was also a visiting professor for the Immunology courses at Institut Pasteur/University of Paris from 1992 to 2010.

After graduating cum laude in Medical Biology, Eric attained his PhD in Medicine some 30 months later in 1987 and spent 9 years at TNO Prevention an Health (vaccines and autoimmunity) after which period he became R&D director and deputy CEO at the Dutch Institute for Animal Science and Health (700 employees; 1996-2001) where he transformed the civilservant institute in a company with 5 successful spin-outs. Since 2001, he is self employed and combines many investments and functions all related to his main focus on research management, valorization and business development in life sciences with a special emphasis on immunology (SMBWO board certified), microbiology, virology & vaccines. Eric is an author on over 200 peer reviewed (and highly quoted; see PubMed under E Claassen, and H-factor of 35 per 2012) papers and several patents.

Eric remarried (Conny Kruyssen) after losing his wife Dr. Suzan Jeurissen to breast cancer (Feb 2003) and is a father of five+1 children. He is an avid sailor, marksman and photographer, is fluent in English and Dutch, and he has adequate reading and conversational skills in Spanish, Catalan, French and German.